Protocol for generation and engineering of thyroid cell lineages using CRISPR-Cas9 editing to recapitulate thyroid cancer histotype progression
Vincenzo Davide Pantina(University of Palermo), Giorgio Stassi(University of Palermo)
Cited by 3
Related Papers
CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
|Cell stem cell|2014|725
Bone Morphogenetic Protein 4 Induces Differentiation of Colorectal Cancer Stem Cells and Increases Their Response to Chemotherapy in Mice
|Gastroenterology|2010|219
Aurora-A Is Essential for the Tumorigenic Capacity and Chemoresistance of Colorectal Cancer Stem Cells
|Cancer Research|2010|158
PED Mediates AKT-Dependent Chemoresistance in Human Breast Cancer Cells
|Cancer Research|2005|59
Suppressor of Cytokine Signaling 3 Sensitizes Anaplastic Thyroid Cancer to Standard Chemotherapy
|Cancer Research|2009|40